Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

RAs, originally for diabetes, may impact brain health, finding potential benefits for dementia and addiction but inconsistent ...

Diabetes can be expensive to manage ... Your insurance formulary, or the official list of medications that your insurance covers, can help you determine how generics compare in cost to brand ...

The landscape of diabetes management is undergoing a remarkable transformation. Groundbreaking research has uncovered surprising cardiovascular benefits tied to modern medications, offering new ...

Breakthrough research into diabetes medications and stroke prevention Recent groundbreaking research has raised the possibility of a game-changing approach to stroke prevention. A study analyzing ...

The cohort comprised adults age 40 and older with type 2 diabetes who initiated treatment with an SGLT2 inhibitor, DPP-4 inhibitor, or GLP-1 receptor agonist after 2013 and who had active COPD as ...

Certain glucose-lowering drugs were linked to fewer moderate or severe COPD exacerbations in adults with type 2 diabetes Study: Glucose-Lowering Medications and Risk of Chronic Obstructive ...

A network meta-analysis reveals age-dependent variations in efficacy of popular diabetes drugs, with SGLT2 inhibitors showing ...